HP To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Monday
Portfolio Pulse from Avi Kapoor
Several Wall Street analysts have updated their price targets and ratings for various US-listed companies. Thermo Fisher Scientific's target was raised by Citigroup, while Agree Realty's target was cut by Mizuho. Marathon Oil's target was reduced by Morgan Stanley, and CRISPR Therapeutics' target was increased by JMP Securities. Citigroup upgraded NIKE and raised its target. BMO Capital raised J.B. Hunt's target and upgraded the stock. Raymond James increased GMS's target. Jefferies raised Best Buy's target and upgraded the stock. RBC Capital raised Pinterest's target and upgraded the stock. Evercore ISI Group raised HP's target and upgraded the stock.
December 11, 2023 | 12:46 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Mizuho cut Agree Realty Corporation's price target from $67 to $61 and downgraded the stock from Buy to Neutral.
A reduced price target and downgrade to Neutral suggest a less optimistic outlook from Mizuho, which could lead to negative sentiment and a decrease in the stock's short-term price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Morgan Stanley cut Marathon Oil Corporation's price target from $27 to $25 and downgraded the stock from Overweight to Equal-Weight.
The reduction in price target and downgrade to Equal-Weight by Morgan Stanley could dampen investor enthusiasm, potentially leading to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jefferies boosted Best Buy Co., Inc.'s price target from $69 to $89 and upgraded the stock from Hold to Buy.
The upgrade to Buy and increased price target by Jefferies could signal stronger confidence in Best Buy's future performance, which may result in a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
JMP Securities boosted CRISPR Therapeutics AG's price target from $74 to $80 and maintained a Market Outperform rating.
An increased price target and maintained Market Outperform rating indicate a positive view on CRISPR Therapeutics' prospects, which could lead to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Raymond James increased GMS Inc.'s price target from $82 to $85 and maintained an Outperform rating.
The increase in price target and continued Outperform rating from Raymond James could suggest a positive outlook for GMS, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 65
RELEVANCE 80
POSITIVE IMPACT
Evercore ISI Group raised HP Inc.'s price target from $33 to $40 and upgraded the stock from In-Line to Outperform.
The substantial increase in price target and upgrade to Outperform by Evercore ISI Group suggest a strong positive outlook for HP, which could lead to a significant short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
BMO Capital increased J.B. Hunt Transport Services, Inc.'s price target from $200 to $220 and upgraded the stock from Market Perform to Outperform.
An upgrade to Outperform and raised price target by BMO Capital are positive indicators that could attract investor interest and potentially lead to a rise in J.B. Hunt's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Citigroup raised NIKE, Inc.'s price target from $100 to $135 and upgraded the stock from Neutral to Buy.
The upgrade to Buy and a significant increase in price target by Citigroup could generate investor optimism, likely resulting in a positive short-term impact on NIKE's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
RBC Capital raised Pinterest, Inc.'s price target from $32 to $46 and upgraded the stock from Sector Perform to Outperform.
The upgrade to Outperform and a higher price target from RBC Capital may reflect an improved outlook for Pinterest, which could positively influence the stock's short-term price movement.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Citigroup raised Thermo Fisher Scientific's price target from $530 to $575 and maintained a Buy rating.
An increased price target and maintained Buy rating by a major bank like Citigroup typically signals confidence in the company's future performance, potentially leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80